174 related articles for article (PubMed ID: 19072498)
21. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.
McInnes N; Sadlon TJ; Brown CY; Pederson S; Beyer M; Schultze JL; McColl S; Goodall GJ; Barry SC
Oncogene; 2012 Feb; 31(8):1045-54. PubMed ID: 21743493
[TBL] [Abstract][Full Text] [Related]
22. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors.
Frömberg A; Engeland K; Aigner A
Cancer Lett; 2018 Mar; 417():96-111. PubMed ID: 29306014
[TBL] [Abstract][Full Text] [Related]
23. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
24. SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.
Pan Z; Jing W; He K; Zhang L; Long X
Cell Physiol Biochem; 2016; 38(5):1975-83. PubMed ID: 27161300
[TBL] [Abstract][Full Text] [Related]
25. Fluvastatin-mediated down-regulation of SATB1 affects aggressive phenotypes of human non-small-cell lung cancer cell line H292.
Xu HY; Xue JX; Gao H; Na FF; Li H; Zhang T; Lu Y
Life Sci; 2019 Apr; 222():212-220. PubMed ID: 30557545
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
27. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis.
Wang Q; Qian J; Wang F; Ma Z
Oncol Rep; 2012 Dec; 28(6):2029-34. PubMed ID: 22972305
[TBL] [Abstract][Full Text] [Related]
28. Chromatin organizer SATB1 as a novel molecular target for cancer therapy.
Mir R; Pradhan SJ; Galande S
Curr Drug Targets; 2012 Dec; 13(13):1603-15. PubMed ID: 22998183
[TBL] [Abstract][Full Text] [Related]
29. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
[TBL] [Abstract][Full Text] [Related]
30. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
[TBL] [Abstract][Full Text] [Related]
31. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
[TBL] [Abstract][Full Text] [Related]
32. Functional relevance of SATB1 in immune regulation and tumorigenesis.
Sunkara KP; Gupta G; Hansbro PM; Dua K; Bebawy M
Biomed Pharmacother; 2018 Aug; 104():87-93. PubMed ID: 29772444
[TBL] [Abstract][Full Text] [Related]
33. Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.
Meng WJ; Pathak S; Ding ZY; Zhang H; Adell G; Holmlund B; Li Y; Zhou ZG; Sun XF
Cancer Biol Ther; 2015; 16(12):1738-45. PubMed ID: 26528635
[TBL] [Abstract][Full Text] [Related]
34. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion.
Mao L; Yang C; Wang J; Li W; Wen R; Chen J; Zheng J
J Transl Med; 2013 May; 11():111. PubMed ID: 23642278
[TBL] [Abstract][Full Text] [Related]
35. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
36. Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells.
Li QQ; Chen ZQ; Xu JD; Cao XX; Chen Q; Liu XP; Xu ZD
Cancer Sci; 2010 Jan; 101(1):80-6. PubMed ID: 19860849
[TBL] [Abstract][Full Text] [Related]
37. [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance].
Peng ZK; Yang DH; Li XH; Huang Y; Zhang GQ; Zhong KB; Bi MP; Li GH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1207-11. PubMed ID: 21764697
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
39. SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome.
Li Y; Wang J; Yu M; Wang Y; Zhang H; Yin J; Li Z; Li T; Yan H; Li F; Wang X
Leuk Lymphoma; 2018 Oct; 59(10):2405-2413. PubMed ID: 29334836
[TBL] [Abstract][Full Text] [Related]
40. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer.
Ge H; Yan Y; Yan M; Guo L; Mao K
Med Sci Monit; 2020 Jun; 26():e923208. PubMed ID: 32562536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
